Frank Zhao

Frank Zhao has a diverse work experience in various companies. Frank started their most recent role as Group CEO at Uni-Bio Science Group in January 2019. Prior to that, they worked as a CFO at 55tuan.com, BORQS, KingMed Dignostics, and Simcere Pharmaceutical Group.

Frank Zhao attended Beijing University, but no specific information about the degree or field of study was provided.